Premature ejaculation: Diagnosis and pharmacotherapy
International Journal of Pharmaceutical Medicine, ISSN: 1364-9027, Vol: 14, Issue: 6, Page: 313-318
2000
- 8Citations
- 7Captures
Metric Options: Counts1 Year3 YearSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Premature ejaculation (PE) is extremely common, affecting around one-quarter of all men. Men readily recognize their PE but rarely report this to their doctors. When they do the mainstay of treatment has been behavioural therapy, which usually requires the cooperation of sexual partners. This can be effective but relapses are common. No pharmacological agents are approved for use in PE, although some, including anti-depressants, are used off-label. Clinical trials have been completed which show that pharmacological agents are effective in prolonging latency to ejaculation. However, diagnostic criteria vary and only limited attempts have been made to operationalize the definition of PE. A validated symptom-based questionnaire is not available and so end-points have for the main relied on measurements of latency to ejaculation. Whether and how these equate to measures of sexual satisfaction has not been determined.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0034491873&origin=inward; http://dx.doi.org/10.1097/00124363-200012000-00008; http://gateway.ovid.com/ovidweb.cgi?T=JS&PAGE=crossref&AN=00124363-200012000-00008; http://link.springer.com/10.2165/00124363-200012000-00008; http://dx.doi.org/10.2165/00124363-200012000-00008; https://dx.doi.org/10.2165/00124363-200012000-00008; https://link.springer.com/article/10.2165/00124363-200012000-00008; https://dx.doi.org/10.1097/00124363-200012000-00008
Springer Nature America, Inc
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know